Dapagliflozin 10mg + Teneligliptin 20mg is an advanced oral antidiabetic medication used to manage type 2 diabetes mellitus. This combination therapy works through dual mechanisms: Dapagliflozin (10mg) – a sodium-glucose co-transporter 2 (SGLT2) inhibitor, reduces glucose reabsorption in the kidneys, promoting excretion of excess sugar through urine, helping in glycemic control and weight management. Teneligliptin (20mg) – a dipeptidyl peptidase-4 (DPP-4) inhibitor, increases insulin secretion and decreases glucagon levels in a glucose-dependent manner, improving post-meal blood sugar levels. Together, these agents provide synergistic glycemic control, reduce HbA1c levels effectively, and help prevent diabetes-related complications when combined with diet and lifestyle modifications.
